Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy in Vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified With Cancer-Specific Monoclonal Antibody

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-2392
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search